In this exploratory analysis, rivaroxaban was superior to aspirin at reducing the risk of recurrent stroke or systemic embolism among NAVIGATE ESUS trial participants with left ventricular dysfunction https://t.co/ghDfNgZ23q
Bonus Key Point 2 from the article Acute #Migraine Treatment by Dr. Jessica Ailani, which is open to subscribers at https://t.co/Hadh2gLFY8. #neurology#headache#neurotwitter
Thank you for the support. I'm attaching my resignation letter to help change how FDA solicits and integrates AdComm input. It's gratifying how many of you like me care deeply about the FDA and its intended role in promoting high quality science and therapeutics. More to come...
#MondayTip
✍️W. Shakespeare: "All that 𝔤𝔩𝔦𝔰𝔱𝔢𝔯 is not gold"
Not all #DWI restriction is a #stroke
👉https://t.co/cFv47IpBU8
For more on DWI #pitfalls & application in acute stroke:
👉https://t.co/5MAG53A6c6
#NeuroTwitterNetwork